Plasmodium Falciparum

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Clinical Practices for Treating Severe Malaria Caused by P. Falciparum

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women

A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in Tanzania

The Malaria Heart Disease Study

Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance Markers

Safety and Protective Efficacy of Pb(PfCS@UIS4)

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity

ELISA Validation of Hypersensitive Rapid Diagnostic Test Results for Detection of P. Falciparum

Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO

PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis